The intracranial pressure-volume relationship following decompressive hinge craniotomy compared to decompressive

Christian Baastrup Søndergaard1, Chiara Villa2, Christina Jacobsen2

  • 1Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. csoend@gmail.com.

Acta Neurochirurgica
|November 12, 2022
PubMed

Insights

Decompressive hinge craniotomy (DHC) allows for a greater increase in intracranial volume before pressure rises, offering a potential alternative to decompressive craniectomy (DC) for managing elevated intracranial pressure.

Area of Science:

  • Neurosurgery
  • Trauma Surgery
  • Critical Care Medicine

Background:

  • Elevated intracranial pressure (ICP) is a critical concern in neurosurgery.
  • Decompressive craniotomy (DC) is a standard procedure, but decompressive hinge craniotomy (DHC) presents an alternative.
  • Understanding the pressure-volume dynamics of DHC versus DC is crucial for treatment selection.

Purpose of the Study:

  • To compare the pressure-volume relationship between decompressive hinge craniotomy (DHC) and decompressive craniotomy (DC).
  • To evaluate the efficacy of DHC in managing elevated intracranial pressure (ICP).

Main Methods:

  • A human cadaver model was used to compare DHC, DC, and bone plate fixation.
  • An intracranial expandable device was inserted to measure ICP during volume increases.
  • CT scans were performed post-DHC to assess volume changes and bone displacement.

Main Results:

  • DHC allowed a 190 ml intracranial volume increase before ICP exceeded 20 mmHg, compared to 130 ml for fixed bone plate and 290 ml for DC.
  • DHC provided a maximal intracranial volume increase of 84 ml, with a bone displacement of 21 mm.
  • The hinged bone plate in DHC remained stable without misalignment.

Conclusions:

  • Decompressive hinge craniotomy (DHC) significantly increases intracranial volume capacity.
  • DHC can accommodate approximately 60 ml volume increase before ICP exceeds 20 mmHg.
  • DHC shows potential as a sufficient treatment for refractory intracranial hypertension in head injury and cerebral infarction patients.
Abstract